Pancreatic ductal adenocarcinoma (PDAC) is defined by a dense, immunosuppressive tumor microenvironment (TME) enriched with extracellular matrix components, cancer-associated fibroblasts (CAFs), and diverse immune populations. ChIP-seq analysis of resected human PDAC identified MICAL2 as a super-enhancer–associat...
Bharti Garg, E. Mose, Briana Nyugen et al.· Cancer Research· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is characterized by marked spatial heterogeneity and a highly variable immune microenvironment, ranging from myeloid-enriched, immune-suppressive regions to more immune-responsive niches. How tumor epithelial and stromal compartments contribute to these spatial immune states, a...
Yuan Sui, Jonathan R. Weitz, J. Bruning et al.· Cancer Research· 0 citations
Intraductal Papillary Mucinous Neoplasm (IPMN) are pre-malignant lesions of the pancreas with frequent co-mutations in KRAS and GNAS oncogenes. We recently reported pancreatic neoplasia from both primary and metastatic disease with KRAS/GNAS mutations are sensitive to single agent treatment with the FDA approved cell...
Deepa Sheik Pran Babu, Shira Yomtoubian, Ethan Tabibzadeh et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.